Tizanidine Hydrochloride Capsule
Product Images NDC 59651-315

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 59651-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Tizanidine Fig1)

A line graph depicting plasma Tizanidine concentration (ng/mL) over a 24-hour period post-dosing. The chart compares concentrations for 2 mg and 4 mg Tizanidine tablets and capsules, both with and without food intake. Concentration peaks occur within the first few hours, followed by a gradual decline.*

FDA Label Image

Fig2 (Tizanidine Fig2)

A line graph depicting improvement in Ashworth Score over 6 hours post-dose. It compares three groups: 16 mg tizanidine showing the greatest improvement, 8 mg tizanidine with moderate improvement, and placebo with minimal change. The graph includes error bars for each data point.*

FDA Label Image

Fig3 (Tizanidine Fig3)

A chart depicting improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) and placebo. The x-axis marks study weeks (end of titration, end of maintenance, endpoint), and the y-axis shows improvement scores, with tizanidine data points indicating greater improvement versus placebo at all times.*

FDA Label Image

Package Label-principal Display Panel (2 mg (150 Capsules Bottle))

Label for Tizanidine Hydrochloride Capsules 2 mg, a drug for further processing by Aurobindo Pharma Limited. The label shows the quantity of 150 capsules, dosage strength of 2 mg, and states it is Rx only. It includes storage instructions, a warning against interchangeability with Zanaflex tablets, and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (4 mg (150 Capsules Bottle))

Label for Tizanidine Hydrochloride Capsules 4 mg by Aurobindo Pharma Limited. The container holds 150 capsules and includes usage warnings, storage instructions, and a note that the capsules are not interchangeable with tizanidine tablets or Zanaflex. The label specifies to keep out of reach of children and includes distributor information from Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (6 mg (150 Capsules Bottle))

Label for Tizanidine Hydrochloride Capsules 6 mg by Aurobindo Pharma Limited. The label shows the NDC 59651-316-77 and states the package contains 150 capsules for prescription use only. It includes storage instructions, distributor information, and a warning not to interchange with Zanaflex tablets. The label also notes the amount of active ingredient per capsule and has a designated coding area.*

FDA Label Image

Str (Tizanidine Str)

Chemical structure diagram of Tizanidine Hydrochloride showing its molecular framework including a chlorinated pyridine ring and thiazole and imidazoline moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.